xCures

Accelerating Cancer Research. Improving Patient Outcomes. Transforming Oncology.

Always on, always learning, our AI-based precision oncology platform captures Real World Evidence that slashes drug development time and saves lives.

The xcures Transformation_

The Problem_

Clinical Research in
Oncology is in Crisis

Clinical trials
take too long

They cost too
much

There aren’t
enough patients

New treatments
are delayed

Patients die

The solution_

xCures has an AI-based Platform
to Run Perpetual Trials

Creating Real World
Evidence (RWE)

Continuously learning from
every patient's experience

For all patients on all
treatments, all the time

The Impact_

Better treatment decisions

Patients

Access to medications

Superior outcomes

Care optimization

Pay for results

Providers

Tumor Board Software

Pay for what works

Payers

Negotiate the right price

Cover the right patients

Real World Evidence

Fewer patients

Pharmaceuticals Companies

Exponentially more efficicient

Proof it works

Diagnostics

Expert insights

Access to patients

Learn More about How it works

Patients_

xCures connects all patients to the treatments most likely to help them. Data about outcomes is collected constantly, so treatments continuously improve. Trials that put patients first is an idea whose time has come.

Visit Cancer commons ^offsite

About_

The xCures team has decades of experience in the pharmaceutical industry, technology, patient advocacy, AI, clinical research, and commercial strategy. Our strategic partners include some of the biggest players in the clinical oncology field.

Learn More

Updates_

xCures to Implement an Intermediate Size Expanded Access Protocol for ONC201 in H3 K27M-Mutant Gliomas

April 6, 2019

LOS ALTOS, Calif., March 12, 2019 /PRNewswire/ -- xCures and Cancer Commons are pleased to announce a collaboration with Oncoceutics to implement an Expanded Access program for ONC201. Part of this Expanded Access program is an...